As the results shown, the genotype and allele distributions of PNPLA3 I148M were significant different in NAFLD+CHD vs NAFLD groups and in NAFLD vs control groups. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.